Welcome to our dedicated page for Ge Healthcare Technologies SEC filings (Ticker: GEHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The GE HealthCare Technologies Inc. (GEHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware corporation with common stock listed on Nasdaq under the symbol GEHC, GE HealthCare submits periodic and current reports that offer detail on its financial condition, governance, and significant corporate events.
Among the key documents investors often review are Form 10-K annual reports and Form 10-Q quarterly reports, which contain information on the company’s operations across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses. In addition, Form 8-K current reports disclose material events. Recent 8-K filings have described items such as a three-year senior unsecured term loan credit facility, the issuance of senior notes due 2028 and 2035, the intended use of proceeds in connection with an announced acquisition of Intelerad Medical Systems, quarterly financial results, and changes to the board of directors.
Investors interested in GEHC can also use this page to track other filing types, such as registration statements and, when applicable, proxy materials related to governance matters. These documents help explain the company’s capital structure, including senior notes and credit facilities, and outline covenants, events of default, and other terms referenced in the filings.
Stock Titan enhances access to GE HealthCare’s filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points in lengthy documents. This can help users quickly understand the implications of new 10-K, 10-Q, and 8-K filings, as well as monitor developments related to financing arrangements, acquisitions, and other significant events disclosed by GE HealthCare Technologies Inc.
GE HealthCare Technologies insider transaction: Kenneth R. Stacherski, Chief Enterprise Operating Officer, reported two disposals of GEHC common stock on 09/01/2025. The filings show 458 shares and 434 shares were disposed of at a price of $73.73 per share, resulting in 41,430 and 40,996 shares beneficially owned after each reported transaction.
The form states these disposals represent withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The Form 4 was signed by the company’s General Counsel as attorney-in-fact on 09/03/2025.
Holton Adam Y, identified as an officer (Chief People Officer) of GE HealthCare Technologies Inc. (GEHC), reported a transaction dated 09/01/2025. The filing shows 464 shares of GEHC common stock were disposed of at a price of $73.73 per share under transaction code F. The report states these shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. After the withholding, the reporting person beneficially owned 16,768 shares. The Form 4 was signed by an attorney-in-fact, Frank R. Jimenez, on 09/03/2025.
GE HealthCare Technologies Inc. (GEHC) insider report: Taha Kass-Hout, listed as Chief Technology Officer, reported two share dispositions on 09/01/2025 related to withholding to satisfy tax obligations from restricted stock unit vesting. The filings show 1,601 shares disposed at $73.73 and 1,296 shares disposed at $73.73. Following those transactions the report lists 66,246 and 64,950 shares beneficially owned, respectively. The Form 4 was signed by an attorney-in-fact, Frank R. Jimenez, General Counsel and Corporate Secretary, on 09/03/2025.
Philip Rackliffe, an officer (CEO, AVS) of GE HealthCare Technologies Inc. (GEHC), reported multiple share dispositions on 09/01/2025 related to the vesting of restricted stock units. The Form 4 shows shares were withheld to satisfy tax withholding obligations at a price of $73.73 per share. The transactions list dispositions of 165, 134, 204 and 1,388 shares. Following the final reported withholding the filing shows 15,582 shares beneficially owned directly by the reporting person. The Form 4 was signed by counsel as attorney-in-fact on 09/03/2025.
Roland Rott, listed as an officer (CEO, Imaging) of GE HealthCare Technologies Inc. (GEHC), reported transactions on 09/01/2025 involving common stock tied to the vesting of restricted stock units. The Form 4 shows three disposition entries coded F (withholding to satisfy tax obligations) for 685, 690 and 459 shares, each executed at $73.73 per share. The reported amounts of common stock beneficially owned following each reported transaction are 29,550, 28,860 and 28,401 shares respectively. The form is signed on behalf of the reporting person by Frank R. Jimenez as attorney-in-fact.
Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc. (GEHC), reported share dispositions on 09/01/2025. The filing shows two withholding transactions related to the vesting of restricted stock units: 1,699 shares were withheld at $73.73 per share and 1,380 shares were withheld at $73.73 per share to satisfy tax-withholding obligations. After these transactions, Mr. Jimenez beneficially owned 69,873 and 68,493 shares respectively as reported on the form. The transactions are recorded as disposals pursuant to tax withholding and are administrative in nature rather than open-market sales.
James Saccaro, Chief Financial Officer of GE HealthCare Technologies Inc. (GEHC), reported disposals on 09/01/2025. The Form 4 shows two dispositions coded F (withholding of shares to satisfy tax obligations) tied to the vesting of restricted stock units. The transactions show 1,740 shares disposed at $73.73 and 1,498 shares disposed at $73.73. Following the reported transactions, the filings list beneficial ownership amounts of 60,092 shares and 58,594 shares respectively. The Form 4 was submitted by an attorney-in-fact and identifies the transaction as tax withholding related to RSU vesting.
GE HealthCare Technologies Inc. Director and President/CEO Peter J. Arduini reported two dispositions of common stock that occurred on 09/01/2025. The filings show 5,874 shares and 5,472 shares were disposed of at $73.73 per share, for a total of 11,346 shares removed via withholding to satisfy tax obligations tied to the vesting of restricted stock units.
After these transactions Mr. Arduini beneficially owned 173,354 shares on one reported line and 167,882 shares on the other, with all holdings reported as direct ownership. The form indicates the share withholding was used solely to meet tax withholding from RSU vesting.
Kenneth R. Stacherski, an officer of GE HealthCare Technologies Inc. (GEHC), was awarded 10,217 restricted stock units (RSUs) on 08/15/2025. Each RSU converts to one share of GE HealthCare common stock at settlement. The award vests 50% on 08/15/2027 and 50% on 08/15/2028. Following the grant, the reporting person beneficially owns 41,888 shares. The Form 4 was signed by the company General Counsel as attorney-in-fact on 08/19/2025. No derivative transactions or cash purchase price were reported for this grant.
Dodge & Cox reports beneficial ownership of 23,567,950 shares of GE HealthCare Technologies, representing 5.1% of the company's common stock. The filing shows sole voting power for 22,284,487 shares and sole dispositive power for 23,567,950 shares. The reporting person is identified as an investment adviser (IA), and the filing states that Dodge & Cox clients have the right to receive dividends and proceeds from these securities. The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.